Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Common pathogenic mechanisms in AD and ocular degenerative diseases

May 17, 2007

STRIDE preliminary results reveal safety and activity of I-vation Triamcinolone Intravitreal Implant

May 17, 2007

New TrkA receptor agonist potentiates betaxolol antiglaucoma activity

May 16, 2007

Experimental therapies in uveitis presented at the ARVO meeting

May 16, 2007

Long-term inhibition of choroidal neovascularization with engineered ZFP transcription factor

May 15, 2007

Safety established for SNJ-1656 in the treatment of glaucoma

May 15, 2007

Phase III data on difluprednate ophthalmic emulsion in ophthalmic conditions

May 15, 2007

In vitro activity of CLS-1506 against ocular bacterial, fungi and viral pathogens

May 14, 2007

Recent advances in corneal transplantation therapy presented at the ARVO meeting

May 14, 2007

Long-term remissions of ocular Behcet's disease with interferon therapy

May 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...